On 08.01.2019 EFSA published a reasoned opinion on the Art.12 MRL review of sedaxane.
8th January 2019
EFSA publishes Art.12 MRL review sedaxane
08January
8th January 2019
EFSA publishes Art. 12 review MRLs triazoxide
On 08.01.2019 EFSA published an Art. 12 reasoned opinion on triazoxide.
17th December 2018
Pencycuron MRL review EFSA
17December
EFSA published a reasoned opinion on the Article 12 MRL review of pencycuron.
16th November 2018
EFSA opinion on Art.12 MRL confirmatory data picolinafen
16November
EFSA published on 16.11.2018 a reasoned opinion (5489) on the evaluation of confirmatory data following the Art. 12 MRL review for picolinafen.
16th November 2018
Tau-fluvalinate Art. 12 MRL review
On 16.11.2018 EFSA published a reasoned opinion on the Art. 12 review of the MRLs of tau-fluvalinate.
15th November 2018
Pyraclostrobin Art. 12 confirmatory data
15November
On 15.11.2018 EFSA published a reasoned opinion on confirmatory data submitted in the context of the Art. 12 review of pyraclostrobin.
14th November 2018
Cyazofamid EFSA Art.12 confirmatory data reported
14November
On 13.11.2018 EFSA published a reasoned opinion on confirmatory data following the Art. 12 MRL review of cyazofamid (13.11.2018, report 5487).
2nd November 2018
EFSA opinion kresoxim-methyl MRL confirmatory data
02November
On 02.11.2018 EFSA published its reasoned opinion on confirmatory data submitted following the Art. 12 MRLreview of kresoxim-methyl.
30th October 2018
EFSA review imazalil MRLs
30October
On 30.10.2018 EFSA published a reasoned opinion (report 5453) on an updated review of the existing MRLs of imazalil, following new toxicological information.
22nd October 2018
EFSA Art.12 confirmatory data pendimethalin
22October
On 22.10.2018 EFSA published a reasoned opinion (report 5426) on the review of confirmatory data submitted in the framework of the Art. 12 review of MRLs of pendimethalin.
19th October 2018
EFSA Art. 12 confirmatory data pyraflufen-ethyl
19October
On 19.10.2018 EFSA published a reasoned opinion on the review of confirmatory data submitted following the Art. 12 review of pyraflufen-ethyl.
19th October 2018
EFSA Art.12 confirmatory data review dimethomorph
On 19.10.2018 EFSA published its reasoned opinion on the Art. 12 review of dimethomorph.
15th October 2018
EFSA opinion confirmatory data teflubenzuron (MRLs)
15October
On 15.10.2018 EFSA published a reasoned opinion on the confirmatory data following the Art. 12 review of teflubenzuron.
1st October 2018
EFSA Art. 12 review of cyflufenamid MRLs
01October
On 01.10.2018 EFSA published its reasoned opinion on the review of cyflufenamid MRLs under Art. 12.
26th September 2018
EFSA opinion MRLs tembotrione
26September
On 26.092018 EFSA published a reasoned opinion on the MRL review of tembotrione (report 5417).
13th September 2018
EFSA Art. 12 review MRLs fluquinconazole
13September
EFSA published a reasoned opinion on the MRL review of fluquinconazole.
31st August 2018
EFSA reasoned opinion Art. 12 review fenbuconazole
31August
EFSA published an Art. 12 MRL review for fenbuconazole (31.08.2018, report 5399)
30th August 2018
EFSA Art.12 MRL review prochloraz
30August
On 27.08.2018 EFSA published a reasoned opinion the MRL review of prochloraz.
29th August 2018
EFSA Art.12 MRL review sintofen
29August
EFSA published a reasoned opinion on the Art. 12 MRL review of sintofen.
26th August 2018
EFSA Art.12 MRL review napropamide
26August
EFSA published on 24.08.2018 a reasoned opinion on the Art. 12 review of the MRLs of napropamide.